Dowlut-McElroy Tazim, Williams Karen B, Carpenter Shannon L, Strickland Julie L
Department of Obstetrics and Gynecology, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Department of Biomedical and Health Informatics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
J Pediatr Adolesc Gynecol. 2015 Dec;28(6):499-501. doi: 10.1016/j.jpag.2015.03.001. Epub 2015 Mar 10.
To characterize menstrual bleeding patterns and treatment of heavy menstrual bleeding in adolescents with bleeding disorders.
DESIGN, SETTING, AND PARTICIPANTS: We conducted a retrospective review of female patients aged nine to 21 years with known bleeding disorders who attended a pediatric gynecology, hematology, and comprehensive hematology/gynecology clinic at a children's hospital in a metropolitan area.
Prevalence of heavy menstrual bleeding at menarche, prolonged menses, and irregular menses among girls with bleeding disorders and patterns of initial and subsequent treatment for heavy menstrual bleeding in girls with bleeding disorders.
Of 115 participants aged nine to 21 years with known bleeding disorders, 102 were included in the final analysis. Of the 69 postmenarcheal girls, almost half (32/69, 46.4%) noted heavy menstrual bleeding at menarche. Girls with von Willebrand disease were more likely to have menses lasting longer than seven days. Only 28% of girls had discussed a treatment plan for heavy menstrual bleeding before menarche. Hormonal therapy was most commonly used as initial treatment of heavy menstrual bleeding. Half (53%) of the girls failed initial treatment. Combination (hormonal and non-hormonal therapy) was more frequently used for subsequent treatment.
Adolescents with bleeding disorders are at risk of heavy bleeding at and after menarche. Consultation with a pediatric gynecologist and/or hematologist prior to menarche may be helpful to outline abnormal patterns of menstrual bleeding and to discuss options of treatment in the event of heavy menstrual bleeding.
描述患有出血性疾病的青少年的月经出血模式及月经过多的治疗情况。
设计、地点和参与者:我们对年龄在9至21岁、患有已知出血性疾病的女性患者进行了回顾性研究,这些患者在大都市地区一家儿童医院的儿科妇科、血液科以及综合血液科/妇科门诊就诊。
患有出血性疾病的女孩初潮时月经过多、经期延长和月经不规律的患病率,以及患有出血性疾病的女孩月经过多的初始和后续治疗模式。
在115名年龄在9至21岁、患有已知出血性疾病的参与者中,102名被纳入最终分析。在69名初潮后的女孩中,近一半(32/69,46.4%)在初潮时出现月经过多。患有血管性血友病的女孩经期持续超过七天的可能性更大。只有28%的女孩在初潮前讨论过月经过多的治疗方案。激素疗法是最常用于月经过多初始治疗的方法。一半(53%)的女孩初始治疗失败。联合治疗(激素和非激素疗法)在后续治疗中使用得更频繁。
患有出血性疾病的青少年在初潮时及初潮后有大出血的风险。初潮前咨询儿科妇科医生和/或血液科医生可能有助于勾勒月经出血的异常模式,并讨论月经过多情况下的治疗选择。